Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children [PDF]
Bitter, Marieke +6 more
core +2 more sources
Resistance Mutations in CLL: Genetic Mechanisms Shaping the Future of Targeted Therapy. [PDF]
Sekeres S +4 more
europepmc +1 more source
Case Report: dose adjustment of orelabrutinib for managing central nervous system post-transplant lymphoproliferative disorder following acute lymphoblastic leukemia transplantation. [PDF]
Wang W, Chen J, Guan L.
europepmc +1 more source
BTK autoinhibition analyzed by high-throughput swaps of SH2 domains. [PDF]
Eisen TJ +4 more
europepmc +1 more source
Next-generation Bruton tyrosine kinase inhibitors and degraders in the treatment of B-cell malignancies: advances and challenges. [PDF]
Wang Y +5 more
europepmc +1 more source
Bruton tyrosine kinase inhibitor in non-IgM lymphoplasmacytic lymphoma: a case report and literature review. [PDF]
Ito K, Hirano K, Sekiguchi N.
europepmc +1 more source
Microsecond simulations to investigate the structural mechanism of super-resistant double mutations in BTK to the covalent inhibitor ibrutinib in multiple leukemia. [PDF]
Khan A +8 more
europepmc +1 more source
Vascular Endothelial Growth Factors and the Bmx Tyrosine Kinase in the Regulation of Angiogenesis and Lymphangiogenesis [PDF]
Paavonen, Karri
core
Strongyloides stercoralis infection in a DLBCL patient treated with rituximab and BTK inhibitor: A case report and literature review. [PDF]
Liu W +6 more
europepmc +1 more source

